BLEEDING RISK ASSESSMENT

This adverse event was reported 1 times

These drugs are most commonly taken by patients reporting BLEEDING RISK ASSESSMENT:

# Drug Count
0 APIXABAN 1
1 REMIBRUTINIB 1
See all common drugs associated with BLEEDING RISK ASSESSMENT

BLEEDING RISK ASSESSMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 REMIBRUTINIB 1 0.0007
1 APIXABAN 1 0.0000
See all drugs enriched for association with BLEEDING RISK ASSESSMENT

These drug classes are most commonly taken by patients reporting BLEEDING RISK ASSESSMENT:

# Drug class Count
0 Factor Xa Inhibitor [EPC] 1
1 Kinase Inhibitor [EPC] 1
See all common drug classes associated with BLEEDING RISK ASSESSMENT

BLEEDING RISK ASSESSMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Factor Xa Inhibitor [EPC] 1 0.0000
1 Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with BLEEDING RISK ASSESSMENT